A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque Psoriasis

NCT07158268 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: HSK47388

Sponsor

Haisco Pharmaceutical Group Co., Ltd.